Anti-Cyclin E1


Cyclin E1 belongs to cyclin E family that activates cyclin-dependent kinase Cdk2. Cyclin E1 expression is vital for cell cycle control at the late G1 and early S phase. Cyclin E1 Ubiquination by the Cul-3 pathway and Fbw7 regulates cyclin E1 levels and is critically important in normal cells. Cyclin E1-protein expression in normal cells is tightly controlled through a combination of transcriptional and proteolytic regulatory processes. In many types of human tumors, cyclin E1 expression is frequently dysregulated, including overexpression, non-periodic expression relative to cell division, and generation of low molecular weight (LMW) derivatives. Several studies have consistently demonstrated that Cyclin E1 is associated with disease progression or patient survival in various malignancies including carcinomas of the breast, bladder, colon, and ovary. A recent study indicated that cyclin E amplification/overexpression is responsible for trastuzumab resistance in HER2 positive breast cancer patients
Intended Use: IVD
Antibody Type: Monoclonal
Clone: EP126
Source: Rabbit
Tissue Type/Cancer Type: Placenta

Related products

View All